Thymidine kinase 1 concentration and activity in metastatic breast cancer under CDK4/6 inhibitor the...
Thymidine kinase 1 concentration and activity in metastatic breast cancer under CDK4/6 inhibitor therapy
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
We investigated whether TK1 concentration or activity in the blood, drawn at baseline and under therapy, might have value for therapy management in 110 hormone receptor-positive (HR+), HER2-negative (HER2-) metastatic breast cancer (mBC) patients treated with CDK4/6 inhibitors (CDK4/6i) and/or endocrine therapy (ET). TK1 concentration and activity...
Alternative Titles
Full title
Thymidine kinase 1 concentration and activity in metastatic breast cancer under CDK4/6 inhibitor therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d83cbfbe70f248e7ab263ec1cc613c5a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d83cbfbe70f248e7ab263ec1cc613c5a
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-025-95114-7
